Unknown

Dataset Information

0

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.

ABSTRACT:

SUBMITTER: de Michelena P 

PROVIDER: S-EPMC8743856 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.

de Michelena Paula P   Torres Ignacio I   Albert Eliseo E   Bracho Alma A   González-Candelas Fernando F   Navarro David D  

The Journal of infection 20220110 4

Similar Datasets

Unknown Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
| S-EPMC9312404 | biostudies-literature
Unknown Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
| S-EPMC9503182 | biostudies-literature
Unknown Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy.
| S-EPMC8632179 | biostudies-literature
Unknown Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections.
| S-EPMC8282118 | biostudies-literature
Unknown Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.
| S-EPMC8483940 | biostudies-literature
Unknown Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
| S-EPMC8845038 | biostudies-literature
Unknown SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination.
| S-EPMC9146960 | biostudies-literature
Unknown Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era.
| S-EPMC8641954 | biostudies-literature
Unknown Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker.
| S-EPMC8418387 | biostudies-literature
Unknown SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
| S-EPMC8372487 | biostudies-literature